CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
+7.64%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$649M
AUM Growth
+$38.4M
(+6.3%)
Cap. Flow
+$3.18M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
8.38%
Holding
684
New
103
Increased
174
Reduced
151
Closed
77
Top Buys
| 1 |
Applied Materials
AMAT
|
$2.73M |
| 2 |
Wells Fargo
WFC
|
$2.29M |
| 3 |
Lockheed Martin
LMT
|
$2.15M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
$2.05M |
| 5 |
S&P Global
SPGI
|
$2M |
Top Sells
| 1 |
CVS Health
CVS
|
$2.6M |
| 2 |
Broadcom
AVGO
|
$2.56M |
| 3 |
Parker-Hannifin
PH
|
$2.49M |
| 4 |
American Express
AXP
|
$2.36M |
| 5 |
Chubb
CB
|
$2.18M |
Sector Composition
| 1 | Financials | 18.76% |
| 2 | Technology | 17.7% |
| 3 | Healthcare | 14.05% |
| 4 | Industrials | 12.83% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Intuit
INTU
$187B
| $380K | 0.06% |
584
-1
| -0.2% | -$650 |
|
502
Boston Beer
SAM
$2.43B
| $378K | 0.06% |
1,241
| – | – |
|
503
LXP Industrial Trust
LXP
$2.68B
| $366K | 0.06% |
40,568
| – | – |
|
|
SBDS
504
Solo Brands, Inc.
SBDS
$18.8M
| $354K | 0.05% |
162,929
+65,804
| +68% | +$143K |
|
505
Wave Life Sciences
WVE
$1.22B
| $346K | 0.05% |
+56,051
| New | +$346K |
|
506
Amphenol
APH
$136B
| $343K | 0.05% |
5,940
| – | – |
|
507
Tenaya Therapeutics
TNYA
$213M
| $338K | 0.05% |
64,563
-16,692
| -21% | -$87.3K |
|
508
Annexon
ANNX
$238M
| $335K | 0.05% |
46,698
| – | – |
|
509
Ooma
OOMA
$354M
| $328K | 0.05% |
38,472
-678
| -2% | -$5.78K |
|
510
Diodes
DIOD
$2.47B
| $325K | 0.05% |
4,615
| – | – |
|
511
Fate Therapeutics
FATE
$114M
| $322K | 0.05% |
43,812
+2,475
| +6% | +$18.2K |
|
512
Pyxis Oncology
PYXS
$122M
| $319K | 0.05% |
74,903
| – | – |
|
513
Builders FirstSource
BLDR
$16.4B
| $318K | 0.05% |
1,524
| – | – |
|
514
Cullinan Oncology
CGEM
$411M
| $317K | 0.05% |
18,579
-139
| -0.7% | -$2.37K |
|
515
Principal Financial Group
PFG
$17.7B
| $305K | 0.05% |
3,535
| – | – |
|
516
Generation Bio
GBIO
$39.9M
| $302K | 0.05% |
7,417
+3,571
| +93% | +$145K |
|
517
Deckers Outdoor
DECK
$17.5B
| $301K | 0.05% |
1,920
| – | – |
|
518
Monte Rosa Therapeutics
GLUE
$300M
| $299K | 0.05% |
42,393
+14,549
| +52% | +$103K |
|
519
Verastem
VSTM
$648M
| $298K | 0.05% |
25,274
| – | – |
|
|
520
Chubb
CB
$110B
| $292K | 0.04% |
1,126
-8,430
| -88% | -$2.18M |
|
521
Air Products & Chemicals
APD
$64.4B
| $290K | 0.04% |
1,197
+438
| +58% | +$106K |
|
522
Allogene Therapeutics
ALLO
$255M
| $287K | 0.04% |
64,103
+3,469
| +6% | +$15.5K |
|
523
Walt Disney
DIS
$213B
| $282K | 0.04% |
2,303
-91
| -4% | -$11.1K |
|
524
Diamondback Energy
FANG
$39.9B
| $274K | 0.04% |
1,382
-42
| -3% | -$8.32K |
|
525
Nurix Therapeutics
NRIX
$764M
| $272K | 0.04% |
18,511
| – | – |
|